Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04120701 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

Study acronym: CIRCULATE
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 2027 to Mar 2032 Completion date: Jan 2028 to Mar 2032v3 Show 1 more changeShow less
    • Completion date: Jan 2028 to Mar 2032
  2. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Dec 2026 to Jan 2027 · Completion date: Dec 2027 to Jan 2028 · Start date changed from estimate of Dec 2019 to Jan 17, 2020 · 1 morev2 Show 4 more changesShow less
    • Primary completion date: Dec 2026 to Jan 2027
    • Completion date: Dec 2027 to Jan 2028
    • Start date changed from estimate of Dec 2019 to Jan 17, 2020
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of CIRCULATE trial is to improve care of patients after colon tumor surgery, based on an innovative marker: circulating tumor DNA.
Trial Details
NCT Number NCT04120701
Lead Sponsor Centre Hospitalier Universitaire Dijon
Conditions Patients With Resected Stage II Colon Cancer
Enrollment 1,980 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov